Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Capital Expenditures (2019)

Traws Pharma's Capital Expenditures history spans 4 years, with the latest figure at -$1000.0 for Q4 2019.

  • Quarterly results put Capital Expenditures at -$1000.0 for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2023 was -$1000.0 (changed N/A YoY), and the annual figure for FY2025 was $2.6 million, down 29.14%.
  • Capital Expenditures for Q4 2019 was -$1000.0 at Traws Pharma, down from $6000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of -$1000.0 in Q4 2019 to a low of -$1000.0 in Q4 2019.